News

  • Fries linked to increased risk of type 2 diabetes

    Eating French fries three or more times a week could increase the risk of developing type 2 diabetes by 20 per cent, according to new research. The findings are based on data from studies tracking the health of more than 205,000 US medical workers over nearly 40 years. During this period, 22,000 cases of type [...]

  • MS may begin years before classic symptoms emerge – study

    Early signs of multiple sclerosis may emerge up to 15 years before diagnosis, potentially paving the way for earlier detection and treatment. Researchers analysed health records from more than 12,000 people in British Columbia and found that those later diagnosed with multiple sclerosis (MS) used healthcare services at increased rates as early as 15 years [...]

  • Patients coming off obesity jabs should have regular weight check ups, NHS says

    People stopping obesity jabs like Wegovy and Mounjaro should have check-ups for at least a year to help prevent regaining weight, new NHS guidance says. The advice, from the National Institute for Health and Care Excellence (NICE), follows evidence that many people put most of the weight back on after stopping treatment. It warns that [...]

  • Mounjaro shows similar heart benefits to older diabetes drug

    Mounjaro reduced death from any cause by 16 per cent in people with Type 2 diabetes, while offering similar heart protection to an older diabetes drug in a recent trial The nearly five-year trial compared Mounjaro with Trulicity in more than 13,000 adults who had both Type 2 diabetes and cardiovascular disease – a condition [...]

  • Dementia patients waiting to two years for diagnosis, study reveals

    Patients in England are waiting up to two years for a dementia diagnosis, with average delays increasing by more than a third since 2019, a new report has revealed. Average waits from referral to diagnosis have risen from 13 weeks in 2019 to 17.7 weeks, while maximum waits have grown from 34 weeks to two [...]

  • Wasps may hold key to slowing down the ageing process, study suggests

    Jewel wasps can slow their biological ageing by entering a natural dormant state as larvae, scientists have found. Researchers at the University of Leicester discovered that this developmental pause, known as diapause, can extend adult lifespan by over a third and slow the “epigenetic clock” – a molecular marker that tracks chemical changes in DNA [...]

  • Surrey start-ups win funding for dementia tech

    Two Surrey-based start-ups have secured investment to develop digital tools that monitor hydration and track symptom changes in people with dementia. Neu Health and Hydro Care have received backing from the Alzheimer’s Society Accelerator programme. They will collaborate on technologies designed to support families and reduce avoidable hospital admissions. Neu Health has developed a device [...]

  • One in five unaware of diabetes risk factors

    Nearly a fifth of UK adults can’t name a single risk factor for type 2 diabetes, and 68 per cent have never considered their personal risk. The survey found that 19 per cent of respondents could not identify any risk factors for type 2 diabetes, while 20 per cent were unable to name a single [...]

  • Roundup: discover the latest in AI-preventative care and more

    Age Tech World explores the latest business developments in the world of ageing and longevity. Klotho Neurosciences to expand development programmes beyond neurology Klotho Neurosciences has announced that it is evaluating the acquisition of several complementary technologies aimed at supporting healthy brain function, organ health, and longevity. In addition to its core programmes targeting brain [...]

  • Klotho targets ageing beyond brain health

    Klotho Neurosciences is exploring new technologies to support brain function, muscle strength, bone health and other key indicators of ageing. The NASDAQ-listed biogenetics company said it plans to move beyond its core focus on brain ageing and neurodegenerative diseases such as ALS, Alzheimer’s and Parkinson’s. It is now evaluating technologies that complement its anti-ageing Klotho [...]